The 3Rs of Cell Therapy

The 3Rs for a good education are “reading, 'riting, and 'rithmetic.” The basis for good health care solutions for the emergent field of cell therapy in the future will also involve 3Rs: regulation, reimbursement, and realization of value. The business models in this new field of cell therapy will involve these 3Rs. This article brings forth realities facing this new industry for its approaches to provide curative health care solutions. Stem Cells Translational Medicine 2017;6:17–21

• Publication year

  2016

• Venue

  Stem Cells Translational Medicine

• Publication date

  2016-08-08

• Fields of study

  Medicine, Business

• Identifiers
  DOI 10.5966/sctm.2016-0180PMID 28170173PMCID 5442742
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Regenerative medicine legislation in Japan for fast provision of cell therapy products

  2016cited by this paper
• The MSC curtain that stops the immune system.

  2015cited by this paper
• Progressive Approval: A Proposal for a New Regulatory Pathway for Regenerative Medicine

  2014cited by this paper
• Cell therapy industry: billion dollar global business with unlimited potential.

  2011cited by this paper
• A perivascular origin for mesenchymal stem cells in multiple human organs.

  2008cited by this paper
• All MSCs are pericytes?

  2008cited by this paper
• The Cutter Incident: How America’s First Polio Vaccine Led to the Growing Vaccine Crisis

  2006cited by this paper
• Mesenchymal stem cells as trophic mediators

  2006cited by this paper
• Polio: An American Story

  2005cited by this paper
• Human mesenchymal stem cells modulate allogeneic immune cell responses.

  2005cited by this paper
• Polycythemia vera: myths, mechanisms, and management.

  2002cited by this paper
• An American Story

  2000cited by this paper
• Transplantation and Changing Management of Organ Failure

  2000cited by this paper
• A history of haemopoietic cell transplantation

  1999cited by this paper
• Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use.

  1995cited by this paper

• A xenogenic-free culture medium for cell micro-patterning systems as cell-instructive biomaterials for potential clinical applications

  2024cites this paper
• Micro-patterned cell populations as advanced pharmaceutical drugs with precise functional control.

  2022cites this paper
• Gene and Cell Therapy in Dental Tissue Regeneration

  2021cites this paper
• Stem cell translational medicine: The Tianjin model revisited

  2021cites this paper
• Biological and microbiological interactions of Ti-35Nb-7Zr alloy and its basic elements on bone marrow stromal cells: good prospects for bone tissue engineering

  2020cites this paper
• Decisions in the Development Lifecycle of Cell and Gene Therapies

  2020cites this paper
• Prospects of Advanced Therapy Medicinal Products-Based Therapies in Regenerative Dentistry: Current Status, Comparison with Global Trends in Medicine, and Future Perspectives.

  2020cites this paper
• STEM CELL THERAPIES, GENE-BASED THERAPIES, OPTOGENETICS, AND RETINAL PROSTHETICS: Current State and Implications for the Future

  2019cites this paper
• Osteogenic ability of rat bone marrow concentrate is at least as efficacious as mesenchymal stem cells in vitro.

  2019cites this paper
• International Expert Consensus on a Cell Therapy Communication Tool: DOSES

  2019cites this paper
• Functional Tissue Engineering of Ligament and Tendon Injuries

  2019cites this paper
• Decentralised manufacturing of cell and gene therapy products: Learning from other healthcare sectors.

  2018cites this paper
• Report of the Key Opinion Leaders Meeting on Stem Cell-derived Beta Cells.

  2018cites this paper
• Stem cell therapy for stroke: lessons learned from recent successful randomized trials of interventional therapy for stroke

  2018cites this paper
• Clinical Development and Commercialization of Advanced Therapy Medicinal Products in the European Union: How Are the Product Pipeline and Regulatory Framework Evolving?

  2017cites this paper
• A quantitative, multi-national and multi-stakeholder assessment of barriers to the adoption of cell therapies

  2017cites this paper
• Engineering the geometrical shape of mesenchymal stromal cells through defined cyclic stretch regimens

  2017cites this paper
• Concise Review: Multifaceted Characterization of Human Mesenchymal Stem Cells for Use in Regenerative Medicine

  2017cites this paper